《新股消息》據報智能自動售貨機製造商友寶考慮在港IPO 或籌資達5億美元
《彭博》引述知情人士報道,中國智能自動售貨機製造商友寶正考慮在香港進行IPO,籌資規模或高達5億美元。目前,該公司正與顧問就潛在上市事宜進行合作,並考慮最早在今年稍後時候上市。不過相關事項仍在商議之中,例如IPO規模、時間等細節仍可能有變。
知情人士指,友寶亦考慮在IPO前進行一輪融資,但尚未最終確定融資規模。而公司目前估值約為10億美元。
根據友寶官網介紹,公司自2011年成立,為國內智能零售專業平台服務商,阿里巴巴經濟體的戰略合作夥伴,至今已在300餘城市布局,運營智能貨櫃、智能售貨機等多種智能零售終端超10萬台。另外,公司2019年曾進行過一輪融資,募集16億元人民幣,由螞蟻集團領投。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.